Establishment and Application of an Artificial Intelligence Algorithm for Automatic Identification of Intraoperative Bleeding During Laparoscopic Pancreaticoduodenectomy

Laparoscopic Pancreaticoduodenectomy Clinical Trial

Official title:

Establishment and Application of an Artificial Intelligence Algorithm for Automatic Identification of Intraoperative Bleeding During Laparoscopic Pancreaticoduodenectomy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06172062
• Other study ID #: 2023-1663-2
• Status: Recruiting
• Start date: July 20, 2023
• Est. completion date: March 30, 2024

Study information

• Verified date: December 2023
• Source: West China Hospital
• Contact: He Cai, MD.
• Phone: +862862539242
• Email: 813021545[@]qq.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Surgeons will label surgical videos of laparoscopic pancreaticoduodenectomy with bleeding information from multicenter. The labeled surgical video will be used as training material to train the algorithmic model so as to build an artificial intelligence algorithm that can automatically identify intraoperative bleeding in this surgery. Then, we will test the performance capability of the algorithm.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: March 30, 2024
• Est. primary completion date: December 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. surgical videos that recorded complete laparoscopic pancreaticoduodenectomy including resection and reconstruction phases. Exclusion Criteria: 1.surgical videos that recorded laparoscopic pancreaticoduodenectomy combined with resection and reconstruction of mesentericoportal vein.

Related Conditions & MeSH terms

• Blood Loss, Surgical
• Laparoscopic Pancreaticoduodenectomy

Intervention

Other:
• laparoscopic pancreaticoduodenectomy
we recorded the surgical videos of laparoscopic pancreaticoduodenectomy, and labeled the information in the video to build and test the algorithms.

Locations

Country	Name	City	State
China	West China Hospital of Sichuan University	Chengdu	Sichuan

Sponsors (1)

Lead Sponsor	Collaborator
Xinrui Zhu,MD

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	performance of artifical intelligence algorithm	test the performance of the algorithm , including accuracy	through study completion, an average of 1 month